The prognosis for hEDS and HSD varies widely between individuals. These conditions are generally chronic and lifelong, but they are not considered degenerative in the same way as progressive neurologic or autoimmune diseases. The underlying connective tissue differences remain present, but symptom severity and functional impact can change over time.
Many people experience symptom fluctuation, with periods of improvement and periods of worsening related to injury, stress, hormonal changes, deconditioning, or comorbid conditions. Some individuals develop significant disability, while others are able to maintain active, independent lives with appropriate management.
Prognosis is often more favorable when the condition is recognized early and when management focuses on joint protection, strength and stability training, and treatment of associated conditions. Delayed diagnosis, repeated injuries, and lack of appropriate guidance can contribute to worsening pain cycles and functional decline, but these patterns are often modifiable.
Importantly, improvement is common even without a “cure.” With appropriate interventions, many people experience reduced pain, improved stability, fewer injuries, and better day-to-day function over time. The overall trajectory is highly individual, but meaningful improvement is a realistic expectation for many patients when care is tailored appropriately.